N1b期甲状腺乳头状癌淋巴结清扫范围与预后:多中心回顾性队列研究
该多中心回顾性队列纳入2008年5月至2023年5月中国西南5家三级医院2695例单侧N1b期甲状腺乳头状癌患者,均行甲状腺全切及中央区和侧颈区治疗性淋巴结清扫。分析检出淋巴结数目与临床结局的关联,发现检出淋巴结数目增多与持续/复发疾病风险降低相关,全队列在30枚处趋于平台。
要点
- N1b甲状腺乳头状癌初次手术检出淋巴结数目增多与持续/复发风险降低相关。
- 全队列持续/复发风险在检出30枚淋巴结处趋于平台。
- T2-T4亚组检出31枚淋巴结时预后改善最显著。
核心结论
- N1b期甲状腺乳头状癌初次手术检出淋巴结数目增多与更好的临床结局相关。
研究设计与样本
- 多中心回顾性队列研究,纳入中国西南5家三级医院2008年5月至2023年5月单侧N1b期甲状腺乳头状癌行甲状腺全切及中央区和侧颈区治疗性淋巴结清扫的患者2695例,中位年龄38岁(范围18-79岁),男性791例(29.4%)。
- 采用单因素和多因素校正Cox比例风险模型评估检出淋巴结数目与临床结局的关联,并用限制性立方样条模拟非线性关联。
主要发现
- 全队列中检出淋巴结数目增多与持续和复发疾病风险降低相关,在检出30枚淋巴结处趋于平台(HR 0.97,95%CI 0.95-0.98,P < .001)。
- T2-T4亚组中检出31枚淋巴结的预后改善最显著。
- T1亚组中检出淋巴结数目增多与预后更优呈线性趋势。
临床怎么用
- 对N1b期甲状腺乳头状癌,初次手术应充分清扫并送检淋巴结以增加检出数目,可能有助于改善预后。
- 可参考全队列30枚检出淋巴结的平台效应及T2-T4亚组31枚的改善信号,但需结合患者分期与手术风险个体化决策。
局限性
- 为回顾性队列研究,存在选择偏倚和混杂可能。
- 检出淋巴结数目受病理取材和手术方式影响,不能完全代表清扫范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimum extent of neck lymphadenectomy on disease prognosis is unclear in papillary thyroid cancer with laterocervical lymph node metastasis (N1b), despite the need for such data to help guide practice. This study aims to assess the independent impact of the number of examined lymph nodes on clinical outcomes in N1b papillary thyroid cancer patients. METHODS: In this cohort study, patients diagnosed with unilateral N1b papillary thyroid cancer who underwent total thyroidectomy with therapeutic lymph node dissection of the central and lateral compartments at 5 tertiary care hospitals in southwestern China from May 2008 through May 2023 were retrospectively analyzed. Univariate and multivariable-adjusted Cox proportional hazards models were constructed to evaluate the association between the number of examined lymph nodes and clinical outcomes. Restricted cubic spline functions were employed to model the nonlinear association between the number of examined lymph nodes and persistent and recurrent disease risk. RESULTS: Overall, 2,695 patients were included (median [range] age, 38 [18-79] years; 791 men [29.4%]). An increasing number of examined lymph nodes was associated with reduced risk of persistent and recurrent diseases, plateauing at 30 examined lymph nodes (hazard ratio, 0.97; 95% confidence interval, 0.95-0.98; P < .001) in the whole cohort. In T stage-specific subgroup analysis, the T2-T4 subgroup with 31 examined lymph nodes had the most striking prognosis improvements. A linear trend for superior prognosis based on increasing number of examined lymph nodes was found in the T1 subgroup. CONCLUSION: This large cohort study indicated that an increasing number of examined lymph nodes in initial surgery is associated with better clinical outcomes for N1b papillary thyroid cancer patients.
引用
- Liu C, Liu L, Wu J, et al. Extent of lymphadenectomy and prognosis in N1b papillary thyroid cancer: A multicenter retrospective cohort study. Surgery. 2026. PMID: 42546578. doi:10.1016/j.surg.2026.110442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。